Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Paul Kubler"'
Autor:
George John, Jason A. Roberts, Mohd H. Abdul-Aziz, Reza Reyaldeen, Robert G. Fassett, Matthew J. Roberts, Jeffrey Lipman, Jacobus P.J. Ungerer, Paul Kubler, Dwarakanathan Ranganathan, Megan Purvey, Helen Healy, Brett C. McWhinney, Aaron Lim
Publikováno v:
Therapeutic Drug Monitoring
Mycophenolate mofetil (MMF) or enteric coated mycophenolate sodium (EC-MPS) and steroids are used for induction and maintenance therapy in severe lupus nephritis (LN). Blood concentrations of mycophenolic acid (MPA), the active metabolite of these dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2605fe6d9335096cd0cf29e7065d5d7a
https://doi.org/10.1097/ftd.0000000000000658
https://doi.org/10.1097/ftd.0000000000000658
Publikováno v:
Australian journal of general practice. 50(12)
Background An understanding of skin conditions associated with rheumatic diseases ensures accurate diagnosis and management. Cutaneous manifestations of rheumatological disease are legion. Objective The aim of this article is to increase clinician fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a3830028fed64fc1e52b8e9de14769f
https://pubmed.ncbi.nlm.nih.gov/34845466
https://pubmed.ncbi.nlm.nih.gov/34845466
Autor:
Dwarakanathan Ranganathan, Saw Yu Mon, Yumi Oh, Satomi Okano, Valli Manickam, Muriel Soden, Paul Kubler, Drew Joseph Yates
Publikováno v:
Lupus Science & Medicine
ObjectivesThe incidence of serious infections is poorly defined in patients with lupus nephritis (LN). It is also unclear if LN influences risk of serious infections in a longitudinal analysis. The aim of this study was to determine the incidence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6635d1a5aa40c7505925667c8f731391
http://europepmc.org/articles/PMC7509980
http://europepmc.org/articles/PMC7509980
Autor:
Jason A. Roberts, Paul Kubler, Gordon McGurk, Andrew M. Redmond, Alexandra Markwell, Ian Coombes
Publikováno v:
Australian Prescriber
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab68b224d5f688ee5c7dadfef6076a84
https://doi.org/10.18773/austprescr.2020.030
https://doi.org/10.18773/austprescr.2020.030
Publikováno v:
Rheumatology. 59:3108-3109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a3d2a56746e8c63b2d1474ac04dec22
https://doi.org/10.1093/rheumatology/keaa085
https://doi.org/10.1093/rheumatology/keaa085
Publikováno v:
Internal Medicine Journal. 47:1460-1462
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34ac5ad020e39d16633394fe2bffcad8
https://doi.org/10.1111/imj.13638
https://doi.org/10.1111/imj.13638
Autor:
S.Y. Mon, Valli Manickam, S. Muriel, Paul Kubler, Y. Oh, D. Yates, Satomi Okano, D. Ranganathan
Publikováno v:
Kidney International Reports. 4:S165-S166
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75c489f92d72952bdf3867b1c4fb7285
https://doi.org/10.1016/j.ekir.2019.05.427
https://doi.org/10.1016/j.ekir.2019.05.427
Autor:
Gaurav Singh, Dwarakanathan Ranganathan, Lauren White, Paul Kubler, George John, Sajan Thomas, Patrick Flynn, Mani Thenmozhi, Lakshmanan Jeyaseelan
Publikováno v:
Open Journal of Nephrology. :75-82
Aim: In July 2009, a combined Renal Rheumatology Lupus Vasculitis (RRLV) clinic, the first of its kind for adult patients in Australia, was started at Royal Brisbane & Women’s Hospital. This is an audit of progression of renal disease to assess if
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b96e955a692c6a9b45aab13bdbf9942
https://doi.org/10.4236/ojneph.2015.53012
https://doi.org/10.4236/ojneph.2015.53012
Publikováno v:
Clinical and experimental rheumatology. 35(6)
The aim of this study was to characterise the use and costs of subsidising conventional disease-modifying anti-rheumatic drugs (DMARDs) and biologic DMARDs in Australia from 2004-2014 through pharmaceutical benefits schemes.Dispensing and expenditure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f8a32bc6f1473c0eef34a8bc6df43b44
https://pubmed.ncbi.nlm.nih.gov/28421991
https://pubmed.ncbi.nlm.nih.gov/28421991
Autor:
Paul Kubler
Publikováno v:
Australian Prescriber. 41:98-99
Is getting a new drug more quickly onto the market saving patients or putting their safety at risk?
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::191f8ddfdd10545e8cb587b9858b0dab
https://doi.org/10.18773/austprescr.2018.032
https://doi.org/10.18773/austprescr.2018.032